News

Ecnoglutide vs. Semaglutide: FDA Regulatory Pathway and Clinical Trial Outcomes
Ecnoglutide vs. Semaglutide: FDA Regulatory Pathway and Clinical Trial Outcomes
Ecnoglutide remains investigational while semaglutide holds FDA approval. Head-to-head trial data show semaglutide's superior glycemic control but ecnoglutide's better GI tolerability. Read more...